Here are relevant reports on : biotechnology-market
-
CRISPR Market by Product Type (Plasmids, Vectors, CAS9 Nuclease & GRNA, Delivery System), Application (Genetic Engineering, Cell Engineering) & End User (Biotechnology & Pharmaceutical Companies, Contract Research Organization) - Global Forecast to 2023
The global CRISPR market is expected to reach USD 4.16 billion by 2023 from USD 2.01 billion in 2018, growing at a CAGR of 15.7%. Increasing incidences and prevalence of genetic disorders, rising government funding on genomic research, increasing production of genetically modified crops and increasing demand for drug discovery are some of the major factors driving the growth of the global CRISPR market.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Microarray Analysis Market by Product & Service (Consumables, Instrument, Software, Services), Type (DNA, Protein Microarray), Application (Research), End User (Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies) - Global Forecasts to 2023
The global microarray analysis market is projected to reach USD 5.52 billion by 2023, at a CAGR of 7.6%. The major factors driving the growth of this market are the increasing incidence of cancer, increasing funding for genomic and proteomic research, and growing application areas of microarrays. Key players in the microarray analysis market include Thermo Fisher Scientific, Inc. (US), Agilent Technologies, Inc. (US), Molecular Devices (US), PerkinElmer Inc. (US), Illumina, Inc. (US), GE Healthcare (US), and Bio-Rad Laboratories Inc. (US).
- Published: August 2018
- Price: $ 4950
- TOC Available:
-
Healthcare Data Monetization Market by Type (Direct, Indirect), Deployment (On-premise, Cloud), End User (Pharmaceutical & Biotechnology Companies, Healthcare Payers, Healthcare Providers, Medical Technology Companies) & Region- Global Forecast to 2030
The global healthcare data monetization market, valued at US$0.50 billion in 2024, stood at US$0.58 billion in 2025 and is projected to advance at a resilient CAGR of 14.9% from 2025 to 2030, culminating in a forecasted valuation of US$1.16 billion by the end of the period. The growth in this sector is driven by the increasing commercial value of real-time patient data, a growing emphasis on data-driven decision-making in life sciences, and the rise of data-as-a-service (DaaS) business models within healthcare.
- Published: June 2025
- Price: $ 4950
- TOC Available:
-
Viral Clearance Market by Application (Recombinant Proteins, Blood, Vaccines), End User (Pharmaceutical & Biotechnology Companies, CROs), Method (Viral Removal (Chromatography, Nanofiltration), Viral Inactivation (Low pH)) - Global Forecasts to 2023
The global viral clearance market is projected to reach USD 724.5 million by 2023, growing at a CAGR of 21.7%. The key players in the global viral clearance market are Wuxi Biologics (Cayman) (China), Merck KGaA (Germany), Charles River Laboratories International Inc. (US), and Texcell Inc. (France), Kedrion (Italy), Vironova Biosafety (Sweden), Clean Cells (France), BSL BIOSERVICE Scientific Laboratories Munich GmbH (Germany), and ViruSure GmbH (Austria).
- Published: September 2018
- Price: $ 4950
- TOC Available:
-
Drug Discovery Informatics Market by Function (Target Data, Sequencing Data Analysis, Docking), Solution (Software, Services), Application (Drug Development), End User (Pharmaceutical, Biotechnology, Contract Research Organizations) & Region - Global Forecast to 2025
The global drug discovery informatics market growth is primed to transition from $2.2 billion in 2020 to $3.5 billion by 2025, showcasing a strong CAGR of 9.3%. The market is primarily driven by increased R&D spending, especially in rare diseases, and the growing adoption of informatics in drug discovery.
- Published: April 2020
- Price: $ 4950
- TOC Available:
-
Sample Preparation Market by Product (Instruments (Workstations, Liquid Handling Systems), Consumables (Kits, Filters)), Application (Genomics, Proteomics), End Users (Pharmaceutical and Biotechnology, Food and Beverage) - Global Forecast to 2018
The global sample preparation market is expected to grow at a CAGR of 5.5%. Some of the prominent players in the sample preparation market includes Agilent Technologies, Inc. (U.S.), Danaher Corporation (U.S.), Illumina, Inc.(U.S.), QIAGEN N.V.(The Netherlands), PerkinElmer, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Norgen Biotek Corporation (Canada), Hamilton Company (U.S.), Tecan Group Ltd. (Switzerland), Merck (U.S.), Promega Corporation (U.S.), and Roche Applied Science(U.S).
- Published: June 2016
- Price: $ 4950
- TOC Available:
-
Immunoprecipitation Market by Product (Kit, Reagent (Antibodies, Magnetic Buffer)), Type (Individual IP, Coimmunoprecipitation, CHIP), End User (Academics, Research Institutes, Pharmaceutical and Biotechnology Companies) & Region - Global Forecast to 2024
The immunoprecipitation market is projected to reach USD 750 million by 2024, at a CAGR of 5.0%. The growth of this market is majorly driven by the increasing research in the life sciences industry and the growing need to identify antigens associated with autoimmune diseases (through antigen-antibody interaction to understand disease mechanisms and develop relevant drugs targeting these diseases). The prominent players in the global immunoprecipitation market are Thermo Fisher Scientific (US), Abcam (UK), and Merck KGaA (Germany)
- Published: February 2019
- Price: $ 4950
- TOC Available:
-
Healthcare RFID Market by Product (RFID tags, RFID readers, RFID printers), Application (tracking, monitoring), End User (Pharmaceutical and Biotechnology Companies, Hospitals) - Analysis and Global Forecasts to 2021
Radio-Frequency Identification (RFID) uses radio waves to read and capture information stored on a tag attached to an object. This tag can be read from several feet distance and does not need to be within direct line-of-sight of the reader. In healthcare industry, RFID technology can be used in supply chain applications, patient safety, and in quality assurance applications. RFID can be deployed in hospitals and clinics to improve patient flow, reduce medial errors, improve asset utilization rates, and mange inventories & implants, among others.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Trace Metal Analysis Market by Technology Instrument (Atomic Absorption Spectroscopy, X-Ray Fluorescence, ICP-MS), Service (FAAS, ICP-OES)), Application (Food & Beverage, Pharmaceutical & Biotechnology, Environmental Testing) - Global Forecast to 2024
The global trace metal analysis market is projected to reach USD 6.9 billion by 2024 from USD 4.4 billion in 2019, at a CAGR of 9.5%. The growth of this market is mainly driven by the stringent safety and quality regulations and new international cGMP & cGDP certification for pharmaceutical excipients, increasing spending on life science R&D, advancements in technologies, growing preference to outsource analytical requirements to third-party service providers, increasing demand from applied markets, rising opportunities in emerging countries, and the need to comply with revised USP guidelines. Prominent players in the trace metal analysis market are Thermo Fisher Scientific (US), Agilent Technologies (US), PerkinElmer, Inc. (US), Analytik Jena AG (Germany), Bruker Corporation (US), Hitachi Hi-Technologies Corporation (Japan), Rigaku Corporation (Japan), Shimadzu Corporation (Japan), Eurofins Scientific (Luxembourg), Intertek Group PLC (US), SGS S.A. (Switzerland), Bureau Veritas S.A. (France), TÜV SÜD (Germany), and LGC Ltd. (UK).
- Published: April 2019
- Price: $ 4950
- TOC Available:
-
Protein Sequencing Market by Product (Sample Preparation, MS, Sequencer, Reagent, Consumable), Service, Technology (MS, Edman), Application (Biotherapeutics, Genetic Engineering), Enduser (Academia, Pharma, Biotechnology, CROs) - Global Forecasts to 2023
The protein sequencing market is projected to reach USD 1,088 million by 2023, growing at a CAGR of 3.3%. Some of the prominent players in the protein sequencing market include Shimadzu (Japan), Thermo Fisher Scientific Inc. (US), SGS S.A. (Switzerland), Waters Corporation (US), Rapid Novor (Canada), Agilent Technologies (US), Charles River Laboratories (US) and Selvita (Poland).
- Published: November 2018
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
